Child Neurology

This track focuses on the fundamental mechanisms of brain development and dysfunction in children, including genetic, molecular, cellular, and environmental influences that shape the developing nervous system. It explores how alterations in neuronal migration, synaptogenesis, neural circuit formation, neurotransmitter balance, and neuroimmune interactions contribute to a wide range of pediatric neurological conditions such as autism spectrum disorder, epilepsy, cerebral palsy, intellectual disabilities, developmental delays, neuromuscular disorders, and rare neurogenetic syndromes. The session also highlights advances in neurogenomics, epigenetics, brain connectomics, neuroimaging, biomarkers, and computational neuroscience, emphasizing how these innovations are improving early diagnosis, disease prediction, and classification. Strong focus is placed on translational research, precision medicine, gene-based therapies, stem cell interventions, and novel pharmacological strategies aimed at improving long-term neurodevelopmental outcomes in children.

This track focuses on the complex mechanisms, clinical spectrum, and advanced management of epilepsy in children, including focal, generalized, genetic, and drug-resistant epileptic syndromes. It explores the pathophysiology of epileptogenesis, neuronal hyperexcitability, synaptic imbalance, and network-level dysfunction in the developing brain. The session highlights cutting-edge diagnostic tools such as long-term video EEG monitoring, high-density EEG, advanced MRI techniques, PET imaging, and genetic testing that enable precise classification and early detection. Therapeutic approaches include next-generation antiseizure medications, ketogenic and metabolic therapies, immunotherapy in selected cases, vagus nerve stimulation, responsive neurostimulation, and epilepsy surgery for refractory cases. The track also emphasizes precision medicine, AI-based seizure prediction, wearable monitoring technologies, and personalized treatment strategies to improve seizure control, cognitive outcomes, and quality of life.

This track focuses on disorders affecting brain development and function, including autism spectrum disorder, attention-deficit/hyperactivity disorder, intellectual disability, learning disorders, and global developmental delay. It examines the genetic, epigenetic, and environmental factors influencing neurodevelopment, along with alterations in synaptic pruning, connectivity, and cortical maturation. The session highlights early screening tools, behavioral assessment techniques, neuropsychological evaluation, and advanced neuroimaging methods for early diagnosis. It also explores therapeutic interventions including behavioral therapies, cognitive training, pharmacological management, early intervention programs, and digital therapeutics aimed at improving developmental outcomes and functional independence.

This track focuses on the neurobiological and genetic basis of autism spectrum disorders, including disruptions in neural connectivity, synaptic signaling, and social brain networks. It explores early biomarkers, risk genes, environmental influences, and neurodevelopmental trajectories associated with ASD. The session highlights advancements in early detection tools, AI-based behavioral analysis, functional MRI studies, and genetic screening. Therapeutic strategies include applied behavior analysis, speech and occupational therapy, pharmacological interventions for comorbid symptoms, and emerging neuromodulation approaches aimed at improving social communication and adaptive behavior.

This track focuses on the role of genetic and genomic factors in pediatric neurological diseases, including chromosomal disorders, single-gene mutations, mitochondrial diseases, and complex polygenic conditions. It explores advancements in next-generation sequencing, whole-exome and whole-genome analysis, gene mapping, and molecular diagnostics that are transforming disease identification. The session highlights precision medicine approaches, gene therapy, RNA-based therapeutics, and CRISPR-based technologies. Emphasis is placed on early diagnosis of rare neurological disorders, genotype-phenotype correlations, and personalized treatment strategies for improved clinical outcomes.

This track focuses on the pathophysiology, clinical classification, and multidisciplinary management of cerebral palsy and other pediatric movement disorders such as dystonia, ataxia, and spasticity syndromes. It examines perinatal brain injury, hypoxic-ischemic encephalopathy, and neurodevelopmental disruptions affecting motor control systems. The session highlights advances in neurorehabilitation, physiotherapy, occupational therapy, robotic-assisted therapy, botulinum toxin use, orthopedic interventions, and neurosurgical techniques. It also explores neuroplasticity-based rehabilitation strategies and emerging technologies for improving mobility and functional independence.

This track focuses on ischemic and hemorrhagic stroke in children, including risk factors such as congenital heart disease, infections, trauma, and genetic conditions. It explores cerebral blood flow regulation, vascular malformations, and stroke pathophysiology in the developing brain. The session highlights rapid diagnostic imaging, acute stroke management protocols, thrombolysis considerations, and neurocritical care approaches. Long-term management includes rehabilitation, cognitive recovery, and prevention of recurrence through multidisciplinary care.

This track focuses on diseases affecting peripheral nerves, neuromuscular junctions, and muscles, including Duchenne muscular dystrophy, spinal muscular atrophy, myopathies, and neuropathies. It explores genetic causes, protein dysfunction, and motor unit degeneration. The session highlights advances in gene therapy, exon-skipping drugs, enzyme replacement therapy, supportive respiratory care, and physical rehabilitation strategies aimed at improving survival and quality of life.

This track focuses on modern imaging techniques used in pediatric neurology, including MRI, functional MRI, diffusion tensor imaging, PET, and CT-based assessments. It explores how neuroimaging helps in diagnosing structural, functional, and metabolic brain disorders. The session highlights AI-based image analysis, brain mapping technologies, and multimodal imaging approaches that improve diagnostic precision and treatment planning.

This track focuses on rare and orphan neurological disorders, including metabolic, genetic, and degenerative conditions. It explores challenges in diagnosis, delayed recognition, and limited treatment options. The session highlights advancements in rare disease registries, genomic diagnostics, personalized medicine, and international collaborative research efforts.

This track focuses on rehabilitation strategies for children with neurological impairments, including physical, cognitive, and occupational therapies. It explores neuroplasticity-driven recovery, assistive technologies, and robotic rehabilitation systems. The session emphasizes multidisciplinary care to improve functional independence and quality of life.

This track focuses on how the brain develops, adapts, and reorganizes throughout childhood. It explores critical periods of development, synaptic pruning, and experience-dependent plasticity. The session highlights how early interventions can positively influence long-term neurological outcomes.

This track focuses on headache disorders in children, including migraine, tension-type headache, and secondary headaches. It explores triggers, genetic factors, and neurovascular mechanisms. The session highlights preventive therapies, lifestyle interventions, and pharmacological management strategies.

This track focuses on sleep-related neurological disorders such as insomnia, parasomnias, sleep apnea, and circadian rhythm disorders. It explores brain mechanisms regulating sleep and their impact on cognitive and behavioral development. The session highlights diagnostic sleep studies and behavioral and medical treatments.

This track focuses on acute neurological emergencies in children, including status epilepticus, traumatic brain injury, infections, and metabolic crises. It explores intensive care management, neuroprotection strategies, and rapid diagnostic approaches in emergency settings.

This track focuses on personalized approaches to diagnosis and treatment based on genetic, molecular, and clinical profiling. It explores targeted therapies, pharmacogenomics, and individualized treatment planning to improve therapeutic outcomes.

This track focuses on cutting-edge therapeutic innovations including gene editing, stem cell therapy, regenerative medicine, and RNA-based treatments. It explores clinical trials and translational research aimed at curing or modifying disease progression.

This track focuses on AI applications in diagnosis, imaging, predictive modeling, and clinical decision-making. It explores machine learning tools for seizure prediction, developmental assessment, and personalized treatment strategies.